AfricaNowInternational

South African President Urges G-7 to Boost COVID-19 Global Program

South African President Cyril Ramaphosa wants the Group of Seven countries to help finance the World Health Organization’s program to boost COVID-19 testing, diagnostics and vaccines, the presidency said Sunday.

Ramaphosa, who joined the summit of the club of rich democracies in England and addressed them on Saturday, said the G-7 countries, which together account for more than half of global output, should support the Access to COVID-19 Tools Accelerator to plug the $16.8 billion funding gap for this year.

“We need to address the substantial financing gap for tests, treatments, critical supplies like oxygen and the health systems that enable testing, treatment and vaccination,” Ramaphosa said in the presidency statement.

The World Health Organization’s ACT Accelerator program for global COVID-19 treatments aims to fast-track production and ensure equitable access to tests, treatments, and vaccines in the fight against COVID-19.

“If all G-7 countries met their fair share target, this initiative would be two-thirds funded – and it would be 90 percent funded if all G-20 countries made their fair share contributions,” Ramaphosa said.

Ramaphosa also urged G-7 members to support the TRIPS waiver on patents for COVID-19 vaccines and engage in negotiations that could help boost vaccine production.

Around 90 percent of African countries will miss a September target to vaccinate at least 10 percent of their populations against the virus as a third wave of the pandemic looms on the continent, the WHO has said.

Africa has now registered five million COVID-19 cases, with the southern Africa region the worst affected, a Reuters tally has shown.

“If the world is to emerge from this grave crisis, it is essential that we work together to mobilize and direct resources to those countries in the greatest need – and that we do so now,” said Ramaphosa.

The G-7 groups the United States, Japan, Germany, Britain, France, Italy and Canada.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Yes, I would like to receive emails from Washington Informer Newspaper. Sign me up!


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker